(Q38601787)

4 September 2017

Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid (English)

1 reference

4 September 2017

1 reference

1 reference

J A Christian

1

1 reference

4 September 2017

G J R Cook

series ordinal

2

1 reference

4 September 2017

C Harmer

series ordinal

3

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

British Journal of Cancer

4 September 2017

1 reference

4 September 2017

89

1 reference

4 September 2017

2

1 reference

4 September 2017

258-261

1 reference

Hürthle cell carcinoma: a critical histopathologic appraisal.

4 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Pharmacological properties of two cloned somatostatin receptors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Characterization of Somatostatin Receptor Subtypes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Molecular Biology of Somatostatin Receptors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

14 September 2017

Hurthle Cell Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Radioiodine treatment for differentiated thyroid cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

[Somatostatin receptor status in non-medullary thyroid carcinoma]

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Iodine-131 labeled anti-CEA antibodies uptake by Hürthle cell carcinoma

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394249

Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases

31 August 2018

1 reference

12 December 2020

Somatostatin receptor expression in Hürthle cell cancer of the thyroid

1 reference

12 December 2020

First report of Hürthle cell carcinoma revealed by octreotide scanning

1 reference

12 December 2020

FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid

1 reference

12 December 2020

Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy

1 reference

12 December 2020

The role of radioactive somatostatin and its analogues in the control of tumor growth

1 reference

12 December 2020

Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma

1 reference

12 December 2020

Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601072

1 reference

Dimensions Publication ID

4 September 2017

0 references

1 reference

4 September 2017

PubMed publication ID

12865913

1 reference